Burney Company’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.18M	Sell	55,769 -35,914	-39%	-$1.11M	0.06%	227
2026 Q1	$2.48M	Buy	+91,683	New	+$3.08M	0.08%	194
2023 Q4	–	Sell	-3,500	Closed	-$37.8K	–	598
2023 Q3	$37.8K	Hold	3,500	–	–	﹤0.01%	561
2023 Q2	$45.1K	Hold	3,500	–	–	﹤0.01%	570
2023 Q1	$46.2K	Hold	3,500	–	–	﹤0.01%	556
2022 Q4	$52.5K	Hold	3,500	–	–	﹤0.01%	539
2022 Q3	$41K	Buy	3,500 +300	+9%	+$4.06K	﹤0.01%	541
2022 Q2	$36K	Hold	3,200	–	–	﹤0.01%	538
2022 Q1	$96K	Hold	3,200	–	–	﹤0.01%	565
2021 Q4	$85K	Hold	3,200	–	–	﹤0.01%	575
2021 Q3	$116K	Hold	3,200	–	–	0.01%	565
2021 Q2	$139K	Hold	3,200	–	–	0.01%	581
2021 Q1	$109K	Hold	3,200	–	–	0.01%	554
2020 Q4	$112K	Hold	3,200	–	–	0.01%	515
2020 Q3	$77K	Hold	3,200	–	–	﹤0.01%	493
2020 Q2	$59K	Hold	3,200	–	–	﹤0.01%	475
2020 Q1	$50K	Hold	3,200	–	–	﹤0.01%	420
2019 Q4	$68K	Buy	+3,200	New	+$65.9K	﹤0.01%	457
2018 Q3	–	Sell	-2,500	Closed	-$71K	–	465
2018 Q2	$71K	Buy	+2,500	New	+$89K	﹤0.01%	440
2018 Q1	–	Sell	-2,500	Closed	-$97K	–	442
2017 Q4	$97K	Buy	+2,500	New	+$95.1K	0.01%	429

Other funds holding RIGL